Sperm-specific glyceraldehyde 3-phosphate dehydrogenase (GAPDS) originates from spermatogenic cells of the human testis. A strong staining of GAPDS was detected in epididymal epithelium, especially in principal cells and basal cells of the epithelium. GAPDS also bound to the fibrous sheet of the sperm tail and inhibited the motility and penetration ability of sperms. The rat model showed that at postnatal day 28 the spermatogenic cells began to express GAPDS protein. By day 60 its expression decreased in spermatogenic cells while it increased in Sertoli cells. After sexual maturation (120 days) GAPDS protein was expressed in both Sertoli cells and elongated sperms. The expression of GAPDS gradually increased with age in the epididymis.

1.
Shen XF, Li JY, Wang HY, Xue JN, Cao QZ, Lian PW, Chen H, Xie MN: Expression and biology identification of the human epididymis-specific gene ESC42 in E. coli. Zhonghua Nan Ke Xue 2005;11:106-111.
2.
Hammerstedt RH, Lardy HA: The effect of substrate cycling on the ATP yield of sperm glycolysis. J Biol Chem 1983;258:8759-8768.
3.
Brooks DE: Activity and androgenic control of glycolytic enzymes in the epididymis and epididymal spermatozoa of the rat. Biochem J 1976;156:527-537.
4.
Edwards YH, Povey S, LeVan KM, Driscoll CE, Millan JL, Goldberg E: Locus determining the human sperm-specific lactate dehydrogenase, LDHC, is syntenic with LDHA. Dev Genet 1987;8:219-232.
5.
Sakai I, Sharief FS, Li SSL: Molecular cloning and nucleotide sequence of the cDNA for sperm-specific lactate dehydrogenase C from mouse. Biochem J 1987;242:619-622.
6.
McCarrey JR, Thomas K: Human testis-specific PGK gene lacks introns and possesses characteristics of a processed gene. Nature 1987;326:501-505.
7.
Boer PH, Adra CN, Lau YF, McBurney MW: The testis-specific phosphoglycerate kinase gene PGK-2 is a recruited retroposon. Mol Cell Biol 1987;7:3107-3112.
8.
Fawcett DW: The mammalian spermatozoon. Dev Biol 1975;44:394-436.
9.
Eddy EM: The scaffold role of the fibrous sheath. Soc Reprod Fertil Suppl 2007;65:45-62.
10.
Mohri H, Suter DA, Brown-Woodman PD, White IG, Ridley DD: Identification of the biochemical lesion produced by α-chlorohydrin in spermatozoa. Nature 1975;255:75-77.
11.
Stevenson D, Jones AR: Production of (S)-3-chloroactaldehyde from (S)-alpha-chlorohydrin by boar spermatozoa and the inhibition of glyceraldehyde-3-phosphate dehydrogenase in vitro. J Reprod Fertil 1985;74:157-165.
12.
Li J, Liu F, Wang H, Liu X, Liu J, Li N, Wan F, Wang W, Zhang C, Jin S, Liu J, Zhu P, Liu Y: Systematic mapping and functional analysis of a family of human epididymal secretory sperm-located proteins. Mol Cell Proteomics 2010;9:2517-2528.
13.
Liu J, Li J, Wang H, Zhang C, Li N, Lin Y, Liu J, Wang W: Cloning, expression and location of RNase9 in human epididymis. BMC Res Notes 2008;1:111.
14.
Shibahara H, Mitsuo M, Inoue M, Hasegawa A, Shigeta M, Koyama K: Relationship between human in-vitro fertilization and intracytoplasmic sperm injection and the zona-free hamster egg penetration test. Hum Reprod 1998;13:1928-1932.
15.
Tanii I, Yagura T, Inagaki N, Nakayama T, Imaizumi K, Yoshinaga K: Preferential localization of rat GAPDS on the ribs of fibrous sheath of sperm flagellum and its expression during flagellar formation. Acta Histochem Cytochem 2007;40:19-26.
16.
Tso JY, Sun XH, Kao TH, Reece KS, Wu R: Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 1985;13:2485-2502.
17.
Robaire B, Viger RS: Regulation of epididymal epithelial cell functions. Biol Reprod 1995;52:226-236.
18.
Zhu CF, Liu Q, Zhang L, Yuan HX, Zhen W, Zhang JS, Chen ZJ, Hall SH, French FS, Zhang YL: RNase9, an androgen-dependent member of the RNase A family, is specifically expressed in the rat epididymis. Biol Reprod 2007;76:63-73.
19.
Shum WW, Da Silva N, McKee M, Smith PJ, Brown D, Breton S: Transepithelial projections from basal cells are luminal sensors in pseudostratified epithelia. Cell 2008;135:1108-1117.
20.
Abe K, Takano H: Early degeneration of the epithelial cells in the initial segment of the epididymal duct in mice after efferent duct cutting. Arch Histol Cytol 1989;52:299-310.
21.
Andrade J, Pearce ST, Zhao H, Barroso M: Interactions among p22, glyceraldehyde phosphate dehydrogenase and microtubules. Biochem J 2004;384:327-336.
22.
Badran HH, Hermo LS: Expression and regulation of aquaporins 1, 8, and 9 in the testis, efferent ducts, and epididymis of adult rats and during postnatal development. J Androl 2002;23:358-373.
23.
Bobaire B, Hermo L: Efferent ducts, epididymis, and vas deferens: structure, functions, and their regulation; in Knobil E, Neill J (eds): The Physiology of Reproduction. New York, Raven Press, 1988, pp 999-1080.
24.
Hoppe PC: Glucose requirement for mouse sperm capacitation in vitro. Gamete Res 1976;15:39-45.
25.
Kasper M, Stosiek P: Immunohistochemical investigation of different cytokeratins and vimentin in the human epididymis from the fetal period up to adulthood. Cell Tissue Res 1989;257:661-664.
26.
Miki K, Qu W, Goulding EH, Willis WD, Bunch DO, Strader LF, Perreault SD, Eddy EM, O'Brien DA: Glyceraldehyde 3-phosphate dehydrogenase-S, a sperm-specific glycolytic enzyme, is required for sperm motility and male fertility. Proc Natl Acad Sci USA 2004;101:16501-16506.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.